These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4350845)

  • 1. Effect of clofibrate on arginine-induced insulin and glucagon secretion.
    Eaton RP
    Metabolism; 1973 Jun; 22(6):763-7. PubMed ID: 4350845
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in man.
    Eaton RP; Schade DS
    Metabolism; 1974 May; 23(5):445-54. PubMed ID: 4825301
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
    Tiengo A; Muggeo M; Assan R; Fedele D; Crepaldi G
    Metabolism; 1975 Aug; 24(8):901-14. PubMed ID: 1143089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese diabetics].
    Cucinotta D; Quartarone M; Saitta A; Sardo A; Squadrito G
    Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2290-6. PubMed ID: 754729
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of clofibrate treatment on arginine-induced insulin secretion in endogenous hypertriglyceridemia.
    Fedele D; Tiengo A; Muggeo M; Nosadini R; Crepaldi G
    Atherosclerosis; 1976; 25(2-3):191-8. PubMed ID: 1008908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese patients].
    Cucinotta D; Quartarone M; Di Cesare E; Longo G; Squadrito G
    Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2283-9. PubMed ID: 754728
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of the hypolipemic effect of clofibrate in postabsorptive man.
    Wolfe BM; Kane JP; Havel RJ; Brewster HP
    J Clin Invest; 1973 Sep; 52(9):2146-59. PubMed ID: 4353773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine infusion in dogs. Model for the roles of insulin and glucagon in regulating glucose turnover and free fatty acid levels.
    Cherrington AD; Kawamori R; Pek S; Vranic M
    Diabetes; 1974 Oct; 23(10):805-15. PubMed ID: 4422477
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of clofibrate on glucose tolerance and insulin secretion in patients with endogenous hypertriglyceridemia (author's transl)].
    Schwandt P; Weisweiler P; Neureuther G; Wilkening J
    MMW Munch Med Wochenschr; 1976 Mar; 118(12):351-4. PubMed ID: 177863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of changes in plasma levels of free fatty acids on plasma glucagon, insulin, and growth hormone in man.
    Hicks BH; Taylor CI; Vij SK; Pek S; Knopf RF; Floyd JC; Fajans SS
    Metabolism; 1977 Sep; 26(9):1011-23. PubMed ID: 895532
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.
    Fenderson RW; Sekowski I; Mohan C; Deutsch S; Benjamin F; Samuel P
    Am J Clin Nutr; 1974 Jan; 27(1):22-8. PubMed ID: 4809201
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynamics of insulin and glucagon secretions in severely burned patients.
    Shuck JM; Eaton P; Shuck LW; Wachtel TL; Schade DS
    J Trauma; 1977 Sep; 17(9):706-13. PubMed ID: 894760
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of short-term clofibrate administration on glucose tolerance and insulin secretion in patients with chemical diabetes or hypertriglyceridemia.
    Ferrari C; Frezzati S; Romussi M; Bertazzoni A; Testori GP; Antonini S; Paracchi A
    Metabolism; 1977 Feb; 26(2):129-39. PubMed ID: 834147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous glucagon regulation in genetically hyperlipemic obese rats.
    Eaton RP; Conway M; Schade DS
    Am J Physiol; 1976 May; 230(5):1336-41. PubMed ID: 1275076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of clofibrate in insulin-dependent ketosis-prone diabetic man.
    Schade DS; Eaton RP; George S; Conway M; Kaminsky N; Sivinski J
    Metabolism; 1978 Apr; 27(4):461-8. PubMed ID: 416322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human maternal and fetal insulin response to arginine.
    King KC; Butt J; Raivio K; Räihä N; Roux J; Teramo K; Yamaguchi K; Schwartz R
    N Engl J Med; 1971 Sep; 285(11):607-12. PubMed ID: 5563962
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women. III. Medroxyprogesterone acetate.
    Beck P; Zimmerman DE; Eaton RP
    Metabolism; 1977 Nov; 26(11):1193-8. PubMed ID: 909395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of clofibrate administration on plasma post-heparin lipolytic activity in man.
    Maruhama Y; Yanbe A; Abe R; Oneda A; Yamagata S
    Tohoku J Exp Med; 1974 Aug; 113(4):343-9. PubMed ID: 4446025
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women: I-Lipid physiology.
    Beck P; Eaton RP; Arnett DM; Alsever RN
    Metabolism; 1975 Sep; 24(9):1055-65. PubMed ID: 1152675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma glucagon in obesity. Response to arginine, glucose and protein administration.
    Kalkhoff RK; Gossain VV; Matute ML
    N Engl J Med; 1973 Aug; 289(9):465-7. PubMed ID: 4587235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.